Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor

by Raynier Devillier, Boris Calmels, Sophie Guia, Mohammed Taha, Cyril Fauriat, Bechara Mfarrej, Geoffroy Venton, Eric Vivier, Daniel Olive, Christian Chabannon, Didier Blaise, Sophie Ugolini
Published 2021-05-01

MANUFACTURING NATURAL KILLER CELLS AS MEDICINAL PRODUCTS

by Christian CHABANNON, Christian CHABANNON, Bechara MFARREJ, Bechara MFARREJ, Sophie GUIA DA SILVA, Sophie UGOLINI, Raynier DEVILLIER, Didier BLAISE, Eric Vivier, Eric Vivier, Boris CALMELS, Boris CALMELS
Published 2016-11-01

NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML

by Anne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, Florence Orlanducci, Samia Harbi, Aude Le Roy, Jérôme Rey, Gaelle Bouvier Borg, Emmanuel Gautherot, Jean-François Hamel, Norbert Ifrah, Catherine Lacombe, Pascale Cornillet-Lefebvre, Jacques Delaunay, Antoine Toubert, Christine Arnoulet, Norbert Vey, Didier Blaise, Daniel Olive
Published 2017-12-01

Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2⁺ γδ T Cell Alterations with Lymph Node Invasion

by Stéphane Fattori, Laurent Gorvel, Samuel Granjeaud, Philippe Rochigneux, Marie-Sarah Rouvière, Amira Ben Amara, Nicolas Boucherit, Magali Paul, Marie Mélanie Dauplat, Jeanne Thomassin-Piana, Maria Paciencia-Gros, Morgan Avenin, Jihane Pakradouni, Julien Barrou, Emmanuelle Charafe-Jauffret, Gilles Houvenaeghel, Eric Lambaudie, François Bertucci, Anthony Goncalves, Carole Tarpin, Jacques A. Nunès, Raynier Devillier, Anne-Sophie Chretien, Daniel Olive
Published 2021-01-01